Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Role of socio-economic and reproductive factors in the risk of multiple sclerosis.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Aerobic intensity and pacing pattern during the six-minute walk-test in patients with multiple sclerosis.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination.
Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease.
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: Results from a longitudinal study.
Efficacy of Tryptophan Immunoadsorption Plasmapheresis for Neuromyelitis Optica in Two Cases.
Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation.
Correlation of the VEMP score, ambulation and upper extremity function in clinically isolated syndrome.
Neuro-nutraceuticals: Further insights into their promise for brain health.
Validity of The Timed Up and Go as A Measure of Functional Mobility in Persons with Multiple Sclerosis.
Prevalence of multiple sclerosis among immigrants in Norway.
Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
[Knowing more about oneself to help one care for others].
Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America.
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy.
Processes of plasma protein N-homocysteinylation in multiple sclerosis.
Personalization of multiple sclerosis treatments: using the chelation therapy approach.
Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis.
Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention.
Microcystic Macular Edema: Retrograde Maculopathy Caused by Optic Neuropathy.
Cross-sectional area variations of internal jugular veins during supine head rotation in multiple sclerosis patients with chronic cerebrospinal venous insufficiency: a prospective diagnostic controlled study with duplex ultrasound investigation.
A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome.
Pages
« first
‹ previous
…
562
563
564
565
566
567
568
569
570
…
next ›
last »